Pfizer (PFE) experienced a pre-market decline of 0.04%, a post-market increase of 0.21%, and a regular session decrease of 0.77% on October 31, 20241.
The decline in Pfizer's stock price during the regular session can be attributed to the broader market trends and economic indicators. The U.S. stocks were under pressure due to rising yields, with the 10-year Treasury yield reaching 4.31%. This tightening of financial conditions and the anticipation of interest rate cuts by the Federal Reserve can lead to volatility in the stock market, affecting Pfizer's stock price. Additionally, disappointing earnings from companies like Microsoft and Meta Platforms, and geopolitical concerns, such as the Middle East situation, can also impact investor sentiment and stock prices23.
In conclusion, Pfizer's stock price decline during the regular session on October 31, 2024, was likely a result of a combination of factors including broader market trends, economic indicators, and geopolitical concerns.
11/1/2024 03:14am
